PDCD1 and neoplasm: Across solid tumors, others have suggested that blockade of the PD-1/PD-L1 pathway leads not only to reinvigoration of preexisting dysfunctional T cells in the tumor microenvironment, but also infiltration of new tumor-reactive T cell clones (18, 19).